The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Revision Applications for Research on Metabolic Reprogramming to Improve Immunotherapy (U01)
This Funding Opportunity Announcement (FOA) invites research project - cooperative agreement (U01) revision applications from investigators with active NIH U01 research project - cooperative agreement awards to support an expansion of the scope of the funded U01 research project through the addition of one or more new specific aims. Revision applications are expected to stimulate collaborative research projects to generate a mechanistic understanding of the metabolic processes that support robust anti-tumor immune responses in vivo, determine how the metabolic landscape of the tumor microenvironment affects immune effector functions, and use this information to manipulate (or reprogram) the metabolic pathways used by the tumor, the immune response, or both to improve cancer immunotherapy.
- Letter of Intent Due Date(s): 30 days before the due date
- Application Due Date(s): July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015, July 11, 2016; December 14, 2016, by 5:00 PM local time of applicant organization.
- AIDS Application Due Date(s): July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015; July 11, 2016; December 14, 2016, by 5:00 PM local time of applicant organization.
PAR-14-086 Expiration Date December 15, 2016
The parent project must be an active NIH U01 project. There must be at least two years (24 months) remaining on the project at the estimated time of award. The PD(s)/PI(s) on the revision must be the same as the PD(s)/PI(s) on the parent grant.